Scientists search for clues in lung cancer tumors
NCT ID NCT07150598
Summary
This study aims to understand how immune system markers in tumor samples relate to treatment response in advanced lung cancer patients receiving standard immunochemotherapy. Researchers will analyze small tumor samples collected before treatment, during treatment, and if the cancer progresses. The study does not test new treatments but seeks to identify markers that might help predict which patients respond best to existing therapies.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for NSCLC (NON-SMALL CELL LUNG CANCER) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Universitätsklinikum Carl Gustav Carus
Dresden, Saxony, 01307, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Köln, Centrum für Integrierte Onkologie (CIO) Köln
Cologne, North Rhine-Westphalia, 50937, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
Conditions
Explore the condition pages connected to this study.